Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lisa Bright Insider Profile
4 Followers
Lisa Bright, Intl. President at Intercept Pharma, holds 22.01K shares in Intercept Pharma (Ticker: ICPT).
Profitable Transactions
21 out of 24 Profitable Transactions
Average Return
+25.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Lisa Bright does not currently own shares as a corporate insider.
A breakdown of Lisa Bright's holdings
Insider Roles
Lisa Bright does not currently hold a role as a corporate insider.
Roles that Lisa Bright holds in companies
Most Profitable Insider Trade
Stock:
Intercept Pharma
(ICPT)
(ICPT)
Rating:Informative Sell
Date:Mar 01, 2017 - Mar 01, 2018
Return:+54.20%
The most profitable trade made by Lisa Bright
Lisa Bright's Trading History
List of latest transactions for each holding click on a transaction to see Lisa Bright's performance on stock
You May Also Like
Lisa Bright insider profile FAQ
What is the percentage of profitable transactions made by Lisa Bright?
The percentage of profitable transactions made by Lisa Bright is 88%.
What is the average return per transaction made by Lisa Bright?
The average return per transaction made by Lisa Bright is 25.70%.
What stocks does Lisa Bright hold?
Lisa Bright holds: ICPT stocks.
What was Lisa Bright’s latest transaction?
Lisa Bright latest transaction was an Uninformative Sell of $14.00K.
What was Lisa Bright's most profitable transaction?
Lisa Bright’s most profitable transaction was an Informative Sell of ICPT stock on March 1, 2017. The return on the trade was 54.20%.
What is Lisa Bright's role in Intercept Pharma?
Lisa Bright's role in Intercept Pharma is Intl. President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.